A novel assay that detects a unique molecular marker in patients with acute myeloid leukemia (AML) may revolutionize the way this disease is detected and treated according to a new report in The Journal of Molecular Diagnostics published by Elsevier.
Novel assay may improve detection and treatment of acute myeloid leukemia
- Post author:
- Post published:November 13, 2023
- Post category:uncategorized